Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.1K Sell
12,771
-989
-7% -$3.09K ﹤0.01% 672
2026
Q1
$40.2K Sell
13,760
-2,073
-13% -$5.92K ﹤0.01% 662
2025
Q4
$39.1K Buy
15,833
+746
+5% +$1.78K ﹤0.01% 611
2025
Q3
$33.6K Buy
+15,087
New +$34.5K ﹤0.01% 860

Other funds holding ABEV

NorthRock Partners's ABEV Position: Q2 2026 in Review

NorthRock Partners reduced its Ambev (ABEV) stake by 7.2% in Q2 2026, selling an estimated $3.09K and leaving 12,771 shares worth $40.1K. The position accounts for ﹤0.01% of the portfolio, ranked #672.

NorthRock Partners first reported a position in ABEV in Q3 2025 and has held it in 4 quarters since. The position peaked at $40.2K in Q1 2026. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • NorthRock Partners held 12,771 shares of Ambev worth $40.1K as of Q2 2026.
  • NorthRock Partners sold 989 Ambev shares in Q2 2026, an estimated $3.09K.
  • Ambev made up ﹤0.01% of NorthRock Partners's portfolio in Q2 2026, its #672 holding.
  • NorthRock Partners first reported a position in Ambev in Q3 2025 and has held it in 4 quarters since.
  • NorthRock Partners's Ambev position peaked at $40.2K in Q1 2026.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.